Expedition Therapeutics Closes $165 Million Series A Financing for COPD Therapy

Wilson Sonsini Goodrich & Rosati has advised Sofinnova Investments, Novo Holdings, and Forbion.Expedition Therapeutics, a biotechnology company specializing in therapies for novel inflammatory and respiratory diseases,…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here